Business Context and Reporting Period
NUR Macroprinters Ltd. (Nasdaq-SCM: NURM), a supplier of wide-format inkjet production printing systems, reported consolidated financial results for the third quarter and nine months ended September 30, 2003. The company is currently consolidating its production facilities in Israel and relocating North American operations to the New York metro area.
Key Financial Metrics
Revenue and Profitability (Q3 2003)
- Revenue: $17.1 million (down from $20.9 million in Q3 2002).
- GAAP Operating Loss: $4.8 million, driven by a $4.5 million inventory write-off.
- Non-GAAP Operating Loss: $328,000 (excluding the write-off), an improvement from $684,000 in Q3 2002.
- GAAP Net Loss: $5.46 million ($0.32 per share).
- Non-GAAP Net Loss: $948,000 ($0.05 per share).
Revenue and Profitability (Nine Months 2003)
- Revenue: $47.3 million (down from $65.7 million in the prior year period).
- GAAP Operating Loss: $21.3 million.
- Non-GAAP Operating Loss: $2.5 million (excluding one-time costs and write-offs).
- GAAP Net Loss: $22.9 million ($1.33 per share).
- Non-GAAP Net Loss: $4.1 million ($0.24 per share).
Liquidity and Balance Sheet
- Cash and Cash Equivalents: $9.3 million (down 21% from year-end 2002).
- Short-term Debt: $11.9 million.
- Long-term Debt: $30.7 million.
- Total Shareholders' Equity: $566,000 (down 98% from year-end 2002 due to accumulated deficits).
Material Changes vs. Prior Period
- Revenue Decline: Q3 revenue decreased primarily due to the discontinuation of the substrate product line, though printer sales increased compared to Q2 2003.
- Inventory Write-off: A $4.5 million write-off occurred due to inventory revaluation following the consolidation of production facilities in Israel.
- Expense Reduction: Operating expenses were reduced, and Days Sales Outstanding (DSO) improved.
- Product Launches: The company launched the NUR Tempo flatbed presses and the NUR Ultima mid-range volume inkjet printers in Q3.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management expects to return to operating profitability and net income in the fourth quarter of 2003. The CEO highlighted successful beta testing and commercial shipping of the Tempo flatbed presses and strong initial reception of the Ultima printers.
Risks and Contingencies
- Debt Covenant Breach: The company failed to meet certain financial covenants in its loan agreements based on Q3 results.
- Waiver Status: NUR is seeking a waiver from its banks. While management believes a waiver will be granted, failure to obtain it would require reclassifying $30.7 million of long-term debt as short-term debt, increasing total short-term debt to $42.6 million.
- Forward-Looking Risks: Risks include general economic conditions, decline in product demand, inability to develop new technologies, and competitive pricing pressure.
Investor Verification Checklist
- Confirm the status of the bank waiver regarding the debt covenant breach and the potential reclassification of long-term debt.
- Verify the timeline for the return to profitability in Q4 2003 against actual results when released.
- Assess the impact of the discontinued substrate product line on future revenue growth.
- Monitor the adoption rates and revenue contribution of the new Tempo and Ultima printer models.
- Review the company's cash burn rate given the significant reduction in shareholders' equity.